Keywords:
Abdomen, Spleen, Oncology, CT, MR, Diagnostic procedure, Pathology, Cancer
Authors:
A. Abrishami1, S. Kooraki1, Y. Abrishami1, L. Grenacher2, H. U. Kauczor3; 1Tehran/IR, 2Munich/DE, 3Heidelberg/DE
DOI:
10.1594/ecr2018/C-1983
Methods and materials
This retrospective study was performed in a tertiary referral center.
Data of patients with incidental spleen lesions in their cross sectional imaging were assessed.
Over a course of three years,
161 patients were included.
Follow-up imaging was performed in 122 individuals with mean (SD) follow-up time of 16.4 (16) months (ranged 1-96 months).
Patients’ demographic data,
morphologic features and enhancement patterns on available CT scan and MRI were carefully reviewed and compared.
Patients with histopathology report indicative of benign lesion,
negative history of malignancy or chemotherapy or with a stable lesion for a minimum of one-year were categorized into benign group.[5,
6] Those in malignant group had either a malignant histopathology or significant change in lesion size without any evidence of infectious lesion or infarct.